Literature DB >> 8087339

Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers.

L J Wesselius1, M E Nelson, B S Skikne.   

Abstract

The lower respiratory tract of cigarette smokers contains an increased amount of iron that is predominantly sequestered within alveolar macrophages (AM), but is also present in alveolar epithelial fluid. Extracellular ferritin-bound iron could potentially be released by reductants present in cigarette smoke and catalyze generation of highly reactive hydroxyl radicals capable of causing oxidant injury. To determine whether AM are a source of alveolar extracellular ferritin and iron, we assessed in vitro release of iron, ferritin, and transferrin by AM recovered by bronchoalveolar lavage (BAL) of 27 healthy subjects including nine nonsmokers (NS), nine light smokers (LS), and nine heavy smokers (HS). Release of iron in vitro over 20 h was increased in AM recovered from LS (2.24 +/- 0.21 nmol/10(6) AM/20 h, p < 0.001) and HS (3.11 +/- 0.32 nmol/10(6) AM, p < 0.001) compared with NS (1.28 +/- 0.08 nmol/10(6) AM). Release of ferritin in vitro over 20 h was also increased in AM recovered from LS (71 +/- 24 ng/10(6) AM, p < 0.05) and HS (176 +/- 35 ng/10(6), p < 0.001) compared with NS (18 +/- 3 ng/10(6) AM). AM recovered from 12 smokers (8 HS, 4 LS) contained greater than 10 nmol of iron per 10(6) cells. These iron-loaded AM released a greater percentage of cell ferritin stores in vitro over 4 h (8.4% +/- 1.1, p < 0.01) than did AM from NS (3.2% +/- 0.6). Release of lactate dehydrogenase (LDH) over 4 h was substantially less (2.9% +/- 0.3, p < 0.001) than ferritin release.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087339     DOI: 10.1164/ajrccm.150.3.8087339

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  25 in total

Review 1.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 2.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Iron metabolism in the lower respiratory tract.

Authors:  F Mateos; J H Brock; J L Pérez-Arellano
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 4.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 5.  Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization.

Authors:  R Steve Pappas
Journal:  Metallomics       Date:  2011-07-28       Impact factor: 4.526

Review 6.  Hyperferritinemia and inflammation.

Authors:  Kate F Kernan; Joseph A Carcillo
Journal:  Int Immunol       Date:  2017-11-01       Impact factor: 4.823

Review 7.  Serum ferritin: Past, present and future.

Authors:  Wei Wang; Mary Ann Knovich; Lan G Coffman; Frank M Torti; Suzy V Torti
Journal:  Biochim Biophys Acta       Date:  2010-03-19

8.  Neutrophil elastase increases airway epithelial nonheme iron levels.

Authors:  Bernard M Fischer; Denise A Lopez Domowicz; Shuo Zheng; Jamie L Carter; N Gerry McElvaney; Clifford Taggart; James R Lehmann; Judith A Voynow; Andrew J Ghio
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

9.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

Review 10.  Glutathione peroxidase-1 as a novel therapeutic target for COPD.

Authors:  Ross Vlahos; Steven Bozinovski
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.